The Lou Ruvo Center for Brain Health, officially the Cleveland Clinic Lou Ruvo Center for Brain Health, opened on May 21, 2010, in Las Vegas, Nevada. It is operated by the Cleveland Clinic and was designed by Frank Gehry.

During the past decade, Cleveland Clinic Lou Ruvo Center for Brain Health conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 23 clinical trials were completed, i.e. on average, 52.3% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 18 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Lou Ruvo Center for Brain Health" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "University of Southern California" with 4 trials sponsored, "Biogen" with 3 trials sponsored, "Genentech, Inc." with 3 trials sponsored and "The Cleveland Clinic" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Lou Ruvo Center for Brain Health" #1 collaborator was "National Institute on Aging (NIA)" with 11 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 4 trials as a collaborator, "Biogen" with 3 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 2 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Lou Ruvo Center for Brain Health" are "Alzheimer's Disease" (19 trials), "Alzheimer Disease" (7 trials), "Multiple Sclerosis" (4 trials), "Multiple Sclerosis, Relapsing-Remitting" (4 trials) and "Parkinson Disease" (4 trials). Many other conditions were trialed in "Cleveland Clinic Lou Ruvo Center for Brain Health" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Lou Ruvo Center for Brain Health" are "Drug" (47 trials), "Other" (4 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Ocrelizumab" (5 trials), "ATH-1017" (2 trials), "Bapineuzumab 0.5 mg/kg" (2 trials) and "Bapineuzumab 1.0 m/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Lou Ruvo Center for Brain Health" are 55 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cleveland Clinic Lou Ruvo Center for Brain Health". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 26 completed trials in Cleveland Clinic Lou Ruvo Center for Brain Health, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Lou Ruvo Center for Brain Health, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".